Journal Article Review Epublish
PubMed: 40075727 DOI: 10.3390/cancers17050880
Revolutionary Cancer Therapy for Personalization and Improved Efficacy: Strategies to Overcome Resistance to Immune Checkpoint Inhibitor Therapy.
Cancers (Basel) 17(5)
Authors: Saud Almawash
Affiliations
- Department of Pharmaceutics, College of Pharmacy, Shaqra University, Shaqra 11961, Saudi Arabia.
Abstract
Cancer remains a significant public health issue worldwide, standing as a primary contributor to global mortality, accounting for approximately 10 million fatalities in 2020 [...].
MeSH
Neoplasms, Biomarkers, Immunotherapy, Immune Checkpoint Inhibitors, Antibodies, Monoclonal, Therapeutics, Artificial Intelligence
Cited by
- Perioperative Management of Non-Small Cell Lung Cancer in the Era of Immunotherapy. Cells, 2025
- Dual role of CXCL10 in cancer progression: implications for immunotherapy and targeted treatment‎. Cancer Biol Ther, 2025
- Immune Checkpoint Molecules in Hodgkin Lymphoma and Other Hematological Malignancies. Cancers (Basel), 2025